Investing.com -- UBS Global Research has upgraded Trainline (LON: TRNT) to a "buy" rating, citing improved fundamentals and ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...

Investing.com -- Verizon (NYSE: VZ) on Friday reported better-than-expected earnings and revenue for the fiscal fourth ...